AB Science (ABSCF) News Today $1.06 0.00 (0.00%) (As of 10/10/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period AB Science: Revenues for the first half of 2024 and update on AB Science’s activitiesOctober 10 at 7:26 PM | markets.businessinsider.comAB Science announces a slight delay in the publication of its 2024 half-year financial reportSeptember 30, 2024 | sg.finance.yahoo.comAB Science provides an update on the microtubule program AB8939 and in particular the ability of AB8939 to generate response on MECOM rearrangementSeptember 26, 2024 | markets.businessinsider.comSUSRF Surgical Science Sweden AB (publ)September 25, 2024 | seekingalpha.comAB Science provides an update on the development of masitinib in progressive forms of multiple sclerosis post ECTRIMS 2024September 23, 2024 | finance.yahoo.comNew study examines the links between science fiction and astronomyAugust 13, 2024 | msn.comSurgical Science Sweden AB (SUSW)August 1, 2024 | investing.comAB Science provides an update on the application for conditional marketing authorisation of masitinib in ALSMay 29, 2024 | finance.yahoo.comAB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036May 13, 2024 | finance.yahoo.comAB Science : A new publication in the medical journal Muscle & Nerve validates the use of the rate of decline of ALSFR-S score (ΔFS) for the design of clinical studies and the treatment choice for amyotrophic lateral sclerosis (ALS) patientMay 7, 2024 | finance.yahoo.com7 Best Ab Exercises That Can Help With Fat Loss By Summer, According To Trainers: Planks & MoreMay 7, 2024 | yahoo.comAB Science : The Paris Court of Appeal confirms the acquittal of the CEO of AB Science, Alain Moussy, and reduces the amount of the financial penalty imposed on AB ScienceMay 2, 2024 | finance.yahoo.comAB Science announces a slight delay in the publication of its 2023 annual financial reportApril 30, 2024 | finance.yahoo.comAB Science ABSCFApril 23, 2024 | morningstar.comAskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in congestive heart failureApril 18, 2024 | markets.businessinsider.comBrandon student off to science fair finalsApril 4, 2024 | msn.comAB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALSApril 3, 2024 | finance.yahoo.comAB Science: New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative diseaseMarch 13, 2024 | finance.yahoo.comAB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science developmentMarch 7, 2024 | finance.yahoo.comAB Science announces that two financial analysis firms, DNA Finance and In Extenso Finance, have initiated coverage of the CompanyMarch 6, 2024 | finance.yahoo.comAB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CETFebruary 29, 2024 | finance.yahoo.comAB Science announces that Health Canada has issued a Notice of Non-Compliance-Withdrawal (NON/w) for masitinib in ALSFebruary 26, 2024 | finance.yahoo.comScience Center ranks among Top 5 USA Today's Readers' Choice Awards for 3 consecutive yearsFebruary 23, 2024 | msn.comAB Science announces an update in the marketing authorization application of masitinib in amyotrophic lateral sclerosis at the European Medicines AgencyJanuary 26, 2024 | finance.yahoo.comAB Science receives notice of allowance for European patent covering masitinib until 2036 in the treatment of mastocytosisJanuary 15, 2024 | finance.yahoo.comAB Science will host a live webcast on Thursday November 30, 2023, from 3pm to 4pm CET, to present the masitinib development program in sickle cell diseaseNovember 28, 2023 | finance.yahoo.comAB Science: The clinical development of masitinib in sickle cell disease is among the 19 winning projects under the sixth call for “Hospital-Inuversity Research in health (RHU)”November 27, 2023 | finance.yahoo.comAB Science ABNovember 13, 2023 | morningstar.comThe head of AB InBev's entertainment studio has exited in the latest marketing shakeup at the Anheuser-Busch parentOctober 31, 2023 | businessinsider.comAB Science today reports its revenues for the first half of 2023 and provides an update on its activitiesSeptember 29, 2023 | finance.yahoo.comABC Moves Forward With ‘Dancing With the Stars’ Premiere After Considering DelaySeptember 25, 2023 | yahoo.comInterest rates will stay high 'as long as necessary': European Central Bank leaderSeptember 25, 2023 | abcnews.go.comThe U.N. system is 'sclerotic and hobbled' and needs urgent reform, top European Union official saysSeptember 22, 2023 | abcnews.go.comAB Science provides an update on the EMA timetable for examination of the masitinib marketing authorization application in ALSSeptember 18, 2023 | finance.yahoo.comEuropean Central Bank raises interest rates for the 10th time in a row to fight inflation despite weak economic growthSeptember 14, 2023 | abcnews.go.comWestern Balkan heads of state press for swift approval of their European Union membership bidsSeptember 11, 2023 | abcnews.go.comEuropean Union home affairs chief appeals for release of Swedish EU employee held in Iranian prisonSeptember 11, 2023 | abcnews.go.comAustralia politics live: Labor dismisses Greens’ attempt to debate Chilean coup as ‘grandstanding’September 11, 2023 | msn.comAustralia politics live: Annastacia Paluszczuk says ‘medical episode’ put her in hospital during Labor’s state conference in JuneSeptember 11, 2023 | theguardian.comHansi Flick out as Germany coach after 4-1 loss to Japan ahead of hosting European ChampionshipSeptember 10, 2023 | abcnews.go.comMcTominay overtakes Ronaldo and Kane to top scoring in European qualifying. Scotland stays perfectSeptember 9, 2023 | abcnews.go.comTikTok's Irish data center up and running as European privacy project gets under waySeptember 5, 2023 | abcnews.go.comTravis Barker's 'urgent family matter' sees Blink-182 postpone European tour datesSeptember 1, 2023 | abcnews.go.comEurope's inflation held steady in August as European Central Bank keeps an open mind on ratesAugust 31, 2023 | abcnews.go.comMore than half of European ski resorts facing 'very high risk' from climate change, study findsAugust 28, 2023 | msn.comMany native bird species have suffered terribly since European settlement. Here are some that have thrivedAugust 25, 2023 | msn.comDutch foreign minister is the 'right man' to fill European Commission post, prime minister saysAugust 25, 2023 | abcnews.go.comWho Are They? 10 European Charter Airlines You May Have Never Heard Of - Part 2August 24, 2023 | msn.comFlames devour forests and homes as wildfires that have left 20 dead in Greece burn out of controlAugust 23, 2023 | abcnews.go.comBest Master’s in Data Science Programs in 2022-23August 9, 2023 | fortune.com Get AB Science News Delivered to You Automatically Sign up to receive the latest news and ratings for ABSCF and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover ABSCF Media Mentions By Week ABSCF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABSCF News Sentiment▼-0.210.71▲Average Medical News Sentiment ABSCF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABSCF Articles This Week▼10▲ABSCF Articles Average Week Get AB Science News Delivered to You Automatically Sign up to receive the latest news and ratings for ABSCF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TGIFF News FFNTF News ACRHF News ACRDF News LBTSF News AZFL News ERBB News AVTBF News AVCNF News BIOYF News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ABSCF) was last updated on 10/11/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe Bible Says it Clear As DayIt came to me clear-as-day thanks to the Bible… in the Parable of Talents, in the book of Matthew… This pa...Prosperity Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AB Science S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share AB Science With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.